James F. Oliviero

2013

In 2013, James F. Oliviero earned a total compensation of $2.3M as Former Chief Financial Officer at Keryx Biopharmaceuticals, a 316% increase compared to previous year.

Compensation breakdown

Bonus$140,000
Non-Equity Incentive Plan$106,000
Option Awards$107,654
Salary$265,000
Stock Awards$1,644,186
Total$2,262,840

Oliviero received $1.6M in stock awards, accounting for 73% of the total pay in 2013.

Oliviero also received $140K in bonus, $106K in non-equity incentive plan, $107.7K in option awards and $265K in salary.

Rankings

In 2013, James F. Oliviero's compensation ranked 3,473rd out of 12,286 executives tracked by ExecPay. In other words, Oliviero earned more than 71.7% of executives.

ClassificationRankingPercentile
All
3,473
out of 12,286
72nd
Division
Manufacturing
1,172
out of 4,612
75th
Major group
Chemicals And Allied Products
316
out of 1,462
78th
Industry group
Drugs
219
out of 1,156
81st
Industry
Pharmaceutical Preparations
181
out of 890
80th
Source: SEC filing on April 15, 2016.

Oliviero's colleagues

We found one more compensation record of an executive who worked with James F. Oliviero at Keryx Biopharmaceuticals in 2013.

2013

Ron Bentsur

Keryx Biopharmaceuticals

Chief Executive Officer

You may also like